| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Outline of Final Research Achievements |
Melanoma only diagnosed less than 10% of all form of skin cancer; however, it is responsible for the majority of skin cancer related death. In 2013, it was estimated that 76.690 new cases of melanoma will be diagnosed in Unites States, and 9.480 people will die due to this disease . When diagnosed in early stage and limited to the skin, the prognosis of melanoma is curable. When it becomes metastatic melanoma, the prognosis is very poor with a 5 years survival rate less than 20%.
By using the grant support, we determined the mechanism of drug-resistance in melanoma and of the suppression of melanoma growth by natural compounds.
|
